2025業績

2025年1月

  1. Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data.
    Hata M, Miyazaki Y, Mori K, Yoshiyama K, Akamine S, Kanemoto H, Gotoh S, Omori H, Hirashima A, Satake Y, Suehiro T, Takahashi S, Ikeda M.
    Scientific Reports. 2025;15:2067.
  2. Neuropsychiatric symptoms and neuroimaging-based brain age in mild cognitive impairment and early dementia: A multicenter study.
    Sone D, Beheshti I, Tagai K, Kameyama H, Takasaki E, Kashibayashi T, Takahashi R, Ishii K, Kanemoto H, Ikeda M, Shigeta M, Shinagawa S, Kazui H.
    Psychiatry and Clinical Neurosciences. 2025;79(4):158-164.
  3. Expressed emotion mediates the association between caregiver relationship closeness and psychological symptoms in people with dementia.
    Liu X, Mo W, Kanaya R, Shigenobu K, Takiue K, Koujiya E, Takeya Y, Yamakawa M.
    Psychogeriatrics. 2025;25(2):e70000.
  4. Characteristics of the Japanese version of the Alzheimer's Disease Cooperative Study Scale for Activities of Daily Living in Mild Cognitive Impairment (ADCS-MCI-ADL-J): preliminary data.
    Ishimaru D, Suzuki M, Katsuki K, Nagata Y, Hirakawa N, Taomoto D, Satake Y, Yoshiyama K, Shigenobu K, Kanemoto H, Ikeda M.
    Psychogeriatrics. 2025;25(1):e13234.

2025年2月

  1. How do caregivers successfully cope with behavioral and psychological symptoms of dementia? A web-based, preliminary analysis using a hybrid approach.
    Yamanaka K, Noguchi D, Sato S, Kosugi N, Kanemoto H, Yoshiyama K, Ikeda M, Kazui H.
    International Psychogeriatrics. 2025:100050.
  2. Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders.
    Yasuda Y, Ito S, Matsumoto J, Okada N, Onitsuka T, Ikeda M, Kushima I, Sumiyoshi C, Fukunaga M, Nemoto K, Miura K, Hashimoto N, Ohi K, Takahashi T, Sasabayashi D, Koeda M, Yamamori H, Fujimoto M, Takano H, Hasegawa N, Narita H, Yamamoto M, Tha K, Kikuchi M, Kamishikiryo T, Itai E, Okubo Y, Tateno A, Nakamura M, Kubota M, Igarashi H, Hirano Y, Okada G, Miyata J, Numata S, Abe O, Yoshimura R, Nakagawa S, Yamasue H, Ozaki N, Kasai K, Hashimoto R.
    Neuropsychopharmacology Reports. 2025;45(1):e70010.

2025年3月

  1. Neuroimaging of psychosis, agitation, and affective disturbance in Alzheimer's disease, dementia with Lewy bodies, and mild cognitive impairment.
    Kanemoto H, Kashibayashi T, Takahashi R, Suehiro T, Satake Y, Taomoto D, Chadani Y, Tagai K, Shinagawa S, Ishii K, Yoshiyama K, Ikeda M, Kazui H.
    International Psychogeriatrics. 2025:100059.
  2. iPSC Screening Identifies CACNA2D2 as a Potential Therapeutic Target for FTLD-tau.
    Imamura K, Nagahashi A, Okusa A, Sakasai T, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Sahara N, Kanaan NM, Higuchi M, Mori K, Ikeda M, Inoue H.
    European Journal of Cell Biology. 2025;104(2):151484.
  3. Late-life parkinsonism in bipolar disorder.
    Nishio Y, Amemiya K, Oyama J.
    Psychogeriatrics. 2025;25(2):e70006.

2025年4月

  1. A Week With a Conversational Large Language Model Companion Robot.
    Satake Y, Ishimaru D, Katsuki K, Rapaport P, Berthouze N, Howard R, Ikeda M.
    The American Journal of Geriatric Psychiatry. 2025;33(7):799-800.
  2. The clinical significance of an AI-based assumption model for neurocognitive diseases using a novel dual-task system.
    Satake Y, Taomoto D, Wu S, Godó Á, Sato S, Suzuki M, Okura F, Yagi Y, Ikeda M.
    Scientific Reports. 2025;15:13989.
  3. Primary Tauopathy With Logopenic/Semantic Mixed Progressive Aphasia and Frontotemporal Dementia-like Behavior.
    Takasaki A, Nishio Y, Satake Y, Kobayashi M, Sakai M, Mori K, Ishii K, Ikeda M.
    Cognitive and Behavioral Neurology. 2025;38(2):60-65.
  4. Nation-wide Japanese FTD consortium FTLD-J: Utility of case review meetings.
    Sato S, Mori K, Masuda M, Suzuki M, Taomoto D, Takasaki A, Shigenobu K, Ouma S, Shinagawa S, Kobayashi R, Watanabe Y, Takeda A, Miyagawa Y, Kawanami A, Tsunoda N, Hara K, Hotta M, Hidaka Y, Yoshiyama K, Kowa H, Katsuno M, Tsujino A, Ikeuchi T, Yabe I, Nakamura M, Tanaka F, Kawakatsu S, Arai T, Yokota O, Izumi Y, Yoshida M, Hashimoto M, Watanabe H, Sobue G, Ikeda M.
    International Psychogeriatrics. 2025:100078.

2025年5月

  1. Predicting models for work outcomes in patients with schizophrenia and its clinical application.
    Sumiyoshi C, Ito S, Matsumoto J, Yamamori H, Fujimoto M, Yasuda Y, Sumiyoshi T, Hashimoto R.
    Scientific Reports. 2025;15:15308.
  2. Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia.
    Kawamata Y, Ohi K, Ito S, Hasegawa N, Yasuda Y, Fujimoto M, Yamamori H, Fukumoto K, Kodaka F, Matsumoto J, Yasui-Furukori N, Hashimoto R.
    Journal of Psychiatric Research. 2025;185:169-176.
  3. A case of dementia with Lewy bodies with psychosis induced by low-dose gabapentinoids.
    Kanemoto H, Akiyama T, Taomoto D, Ikeda M.
    BMC Psychiatry. 2025;25:491.

2025年6月

  1. Electroconvulsive therapy for dementia with Lewy bodies: A systematic review and Japanese multicenter survey.
    Fujishiro H, Iwata-Endo K, Kobayashi R, Morikawa F, Ikeda M.
    Asian Journal of Psychiatry. 2025;108:104510.
  2. Pre-psychosis in later life as a risk factor for progressive cognitive decline: Findings from the IPA psychosis in neurodegenerative disease working group.
    Creese B, Cummings J, Fischer C, Jeste D, Ikeda M, Mills K, Ismail Z, Ballard C.
    International Psychogeriatrics. 2025:100094.

2025年7月

  1. Characteristics of patients with idiopathic normal pressure hydrocephalus for whom neurosurgeons hesitate to perform shunt surgery: a nationwide hospital-based survey in Japan.
    Kawai R, Kazui H, Ueba T, Nakamura N, Minami M, Nakajima M, Yamada S, Kishima H, Kanemoto H, Iseki C, Mori E.
    Fluids and Barriers of the CNS. 2025;22:69.
  2. Thieves in the delusions of theft in patients with Alzheimer's disease living alone: A case series.
    Ishimaru D, Satake Y, Kanemoto H, Taomoto D, Hotta M, Nagata Y, Katsuki K, Ikeda M.
    Journal of Alzheimer's Disease. 2025;106(2):518-522.
  3. Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.
    Goldman JG, Boeve BF, Galasko D, Taylor JP, Galvin JE, Leverenz JB, Blanc F, Halliday G, Kantarci K, Lemstra AW, Leroi I, Lewis SJG, Litvan I, Medsger H, O'Brien J, Scholz SW, Aarsland D, Ikeda M, McKeith I, Taylor A.
    Alzheimer's & Dementia. 2025;21(7):e70470.
  4. Brief operationalized psychosocial interventions for agitation and psychosis: Use in clinical trials and clinical care.
    Ballard C, Mills K, Soto M, Cummings J, Mintzer J, Grossberg G, Ikeda M, Pathak S, Fischer C, McDermid J.
    International Psychogeriatrics. 2025:100118.
  5. Exploring the capabilities of repetitive transcranial magnetic stimulation in major depressive disorder: Dynamic causal modeling of the neural network.
    Kita A, Ishida T, Kita N, Tabata M, Tamaki A, Uenishi S, Yasuda K, Takahashi S, Matsuura H, Yamada S, Kimoto S.
    Translational Psychiatry. 2025;15:257.

2025年8月

  1. Motor involvement in frontotemporal lobar degeneration with TAR DNA-binding protein of 43 kDa type C.
    Yamashita R, Beck G, Shigenobu K, Tarutani A, Yonenobu Y, Kawai M, Mori K, Tahara S, Satake Y, Saito Y, Morii E, Hasegawa M, Ikeda M, Mochizuki H, Murayama S.
    Neuropathology. 2025;45(4):e13026.
  2. Inferring amyloid pathologies among patients with mild cognitive impairment using phase-amplitude coupling of electroencephalography: A case-control study.
    Miyazaki Y, Hata M, Takahashi S, Fukuma R, Taomoto D, Satake Y, Suehiro T, Kanemoto H, Yoshiyama K, Matsunaga K, Isohashi K, Kishima H, Ikeda M, Yanagisawa T.
    International Psychogeriatrics. 2025:100132.
  3. Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group.
    Namasivayam AA, Fischer CE, Abler V, Creese B, Gastiazoro MP, Hermida AP, Ikeda M, Ismail Z, Jeste DV, McDermid J, Mills K, Pathak S, Peschin S, Pot AM, Mintzer J, Sano M, Cummings J, Ballard C.
    International Psychogeriatrics. 2025:100133.
  4. Valuation of cognition bolt-ons for EQ-5D-5L in Japan: A comparative analysis of scaling factor and conventional models.
    Igarashi A, Finch AP, Yang Z, Sakata Y, Azuma-Kasai M, Tomita K, Ishii M, Ikeda M.
    Journal of Alzheimer's Disease. 2025;107(3):1209-1216.
  5. Discovery and development of an oral analgesic targeting the α2B adrenoceptor.
    Toyomoto M, Kurihara T, Nakagawa T, Inoue A, Kimura R, Kii I, Sawada T, Ogihara T, Nagayasu K, Kishi T, Onogi H, Im D, Asada H, Iwata S, Taguchi J, Sumida Y, Yoshida S, Aoki J, Hosoya T, Hagiwara M.
    Proceedings of the National Academy of Sciences of the United States of America. 2025;122(32):e2500006122.

2025年9月

  1. Persistent psychiatric symptoms in apparently well-controlled epilepsy: case report.
    Hata M, Sakagami R, Takahashi S, Ikeda M.
    BJPsych Open. 2025;11(5):e213.
  2. Neural Basis of Anxiety in Dementia With Lewy Bodies.
    Kimura N, Chadani Y, Kawai R, Fujito R, Kanemoto H, Takahashi R, Kashibayashi T, Shinagawa S, Tagai K, Ishii K, Ikeda M, Kazui H.
    International Journal of Geriatric Psychiatry. 2025;40(9):e70150.
  3. A Conversational Robot for Cognitively Impaired Older People Who Live Alone: An Exploratory Feasibility Study.
    Nagata Y, Satake Y, Yamazaki R, Nishio S, Suzuki M, Kanemoto H, Yamakawa M, Figueroa D, Maalouly E, Ishiguro H, Ikeda M.
    Psychogeriatrics. 2025;25(5):e70076.
  4. Clinical Characteristics of Patients With Enlarged Ventricles and Cognitive Impairment (EVCI): Case Series.
    Yasuda Y, Ito S, Matsumoto J, Onitsuka T, Yamamori H, Fujimoto M, Hasegawa N, Ikeda M, Hashimoto R.
    Neuropsychopharmacology Reports. 2025;45(3):e70029.
  5. Psychiatric-onset neuronal intranuclear inclusion disease in a psychiatry-based dementia-enriched cohort in Japan.
    Miyamoto T, Mori K, Akamine S, Kondo S, Gotoh S, Uozumi R, Umeda S, Koguchi-Yoshioka H, Nojima S, Taomoto D, Ikeda M.
    Psychiatry and Clinical Neurosciences. 2025;79(9):561-571.
  6. Clinical and Neuroimaging Features of Tactile Hallucinations in Patients With Dementia With Lewy Bodies: A Cross-Sectional Study.
    Kakeda K, Kanemoto H, Yoshiyama K, Suehiro T, Umeda S, Nakatani Y, Koizumi F, Satake Y, Yamakawa M, Yamamoto Y, Isohashi K, Kato H, Tomiyama N, Hashimoto M, Ikeda M.
    Psychogeriatrics. 2025;25(5):e70082.
  7. Integrating Sleep Monitoring With Health Guidance: An Exploratory Study of Sleep Management in Older Adults.
    Iwase K, Yamakawa M, Higo M, Higami Y, Okumoto A, Koujiya E, Takeya Y, Ikeda M.
    Psychogeriatrics. 2025;25(6):e70098.
  8. Trends in cultural psychiatry in the Korea-Japan Young Psychiatrists' Conference.
    Fujimoto M.
    PRCP & WACP 2025, Tokyo, 2025 Sep 27, symposium.

2025年10月

  1. Correction: Accurate deep-learning model to differentiate dementia severity and diagnosis using a portable electroencephalography device.
    Hata M, Yanagisawa T, Miyazaki Y, Omori H, Hirashima A, Nakagawa Y, Eto M, Yoshiyama K, Kanemoto H, Nyamradnaa B, Yoshimoto S, Ezure K, Takahashi S, Ikeda M.
    Scientific Reports. 2025;15:37976.
  2. Evaluation of Safety and Acceptability of 40 Hz Amplitude-Modulated Auditory Stimulation in Healthy Older People: A Prospective Study from Japan.
    Sato S, Maeda K, Chinen H, Hiroi S, Tanaka K, Ogura E, Fukuju H, Morimoto K, Nagatani Y, Takazawa K, Kasai T, Ohta Y, Ikeda M.
    Healthcare. 2025;13(20):2638.
  3. Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers.
    Sato K, Niimi Y, Ihara R, Iwata A, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Akiyama H, Awata S, Ikeda M, Iwatsubo T.
    Alzheimer's & Dementia. 2025;21(10):e70652.
  4. Dementia care in old age psychiatry over 50 years.
    Lam LCW, Chan WC, Ikeda M.
    International Review of Psychiatry. 2025:1-7.
  5. Structural Characteristics of Docosahexaenoic Acid and Eicosapentaenoic Acid Inhibiting Amyloid-β Fibrillation.
    Yokoi T, Hayashi K, Morihara T, Murai T.
    Biochemistry. 2025;64(19):4242-4253.
  6. Atypical Psychosis in Parkinson Disease: A Retrospective Study on 24-Hour Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa.
    Ge L, Kimura Y, Kakuda K, Ogawa K, Kajiyama Y, Asai K, Taniguchi S, Beck G, Nishio Y, Kim JH, Ikenaka K, Mochizuki H.
    Neurology: Clinical Practice. 2025;15(5):e200534.
  7. Gait and frontal lobe function become associated in patients with idiopathic normal pressure hydrocephalus after shunt surgery.
    Ishikawa M, Mori E, Kazui H.
    Frontiers in Neurology. 2025;16:1647707.
  8. rTMS Therapy for Eating Disorders: Scoping Review on Efficacy, Safety, Stimulation Parameters and Study Subjects.
    Takahashi S, Ikeda S, Ueda M, Harada T, Ishii R.
    European Eating Disorders Review. 2025.

2025年11月

  1. Impact of Urinary Incontinence on Idiopathic Normal Pressure Hydrocephalus: A Cross-Sectional Study With Alzheimer's Disease and Dementia With Lewy Bodies.
    Kanemoto H, Suehiro T, Katakami S, Koizumi F, Satake Y, Taomoto D, Takeda K, Kobayashi M, Yoshiyama K, Ikeda M.
    Geriatrics & Gerontology International. 2025;25:1571.
  2. Real-Time, Multi-center, Dual-Task-Based Cognitive Impairment Screening with Graph Convolutional Neural Networks.
    Godó Á, Wu S, Ikeda M, Sato S, Satake Y, Suzuki M, Shigenobu K, Taomoto D, Yagi Y.
    Pattern Recognition and Computer Vision. ACPR 2025. 2025:370-386.
  3. A zebrafish model of chronic heart failure caused by protein aggregation in heart valves.
    Li Y, Maegawa S, Kimura R, Suzuki SR, Nishimura T, Hagiwara M.
    Communications Biology. 2025;8:1520.
  4. Single-nucleus multiome shows motor neuron glutamate overactivation in amyotrophic lateral sclerosis.
    Takeuchi E, Yasumizu Y, Morita J, Ishikawa M, Ogawa K, Motooka D, Okuzaki D, Nagata M, Ishihara Y, Miyashita Y, Asano Y, Mori K, Morii E, Beck G, Saito Y, Murayama S, Mochizuki H, Nagano S.
    Brain. 2025:awaf426.

2025年12月

  1. Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia.
    Sato K, Niimi Y, Ihara R, Ikeuchi T, Ishii K, Ito K, Iwata A, Kasuga K, Kato T, Kowa H, Nakase T, Senda M, Suzuki K, Tomita N, Tsukamoto T, Yoshiyama K, Iwatsubo T.
    Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2025;11(4):e70167.
  2. Dysgraphia in Japanese patients with primary progressive aphasia.
    Ota S, Suzuki M, Takasaki A, Kawakami N, Morihara K, Kakinuma K, Matsubara S, Katsuse K, Iseki C, Kanno S, Ikeda M, Suzuki K.
    Brain and Language. 2025;271:105655.
  3. The evolving therapeutic landscape of dementia with Lewy bodies.
    Kaila L, Ikeda M, Sultana J, Chouliaras L, O'Brien J, Taylor J-P.
    The Lancet Neurology. 2025;24(12):1038-1052.
  4. EEG Monitoring at Home for Sleep: A Feasibility and Usability Study.
    Livingston G, Rapaport P, Sekitani T, Manela M, Sommerlad A, Nezu T, Yu R-C, Yu C, Satake Y, Araki T, Miyazaki Y, Hata M, Ikeda M.
    The American Journal of Geriatric Psychiatry. 2025.
  5. Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross-diagnostic phenotype predominantly observed in schizophrenia.
    Matsumoto J, Ito S, Sumiyoshi C, Yasuda Y, Hasegawa N, Fujimoto M, Yamamori H, Sumiyoshi T, Hashimoto R.
    Psychiatry and Clinical Neurosciences. 2025.
  6. Predicting dementia severity changes after shunt surgery for idiopathic normal-pressure hydrocephalus: Role of the tap test and cognitive assessments.
    Koizumi F, Kanemoto H, Suehiro T, Sato S, Satake Y, Taomoto D, Yoshiyama K, Hosomi K, Kishima H, Ikeda M.
    Clinical Neurology and Neurosurgery. 2025;261:109288.
  7. Gait Improvement Following Cerebrospinal Fluid Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study.
    Kim M, Park YH, Song YS, Kang K, Park KS, Jeong SY, Lee SW, Ji E, Kim S, Mori E.
    Neurology: Clinical Practice. 2025;15(6):e200549.

2025年業績として掲載する2026年刊行・online first等

  1. PyCaret machine learning library with three preprocessing steps after eLORETA source estimation predicts Alzheimer's disease.
    Aoki Y, Takahashi R, Pascual-Marqui RD, Hata M, Takahashi S, Ishii R, Iwase M, Maenishi M, Kim YO, Yamamoto Y, Hikida S, Maruyama K, Mori E, Ikeda M.
    Neuroimage: Reports. 2026;6(1):100317.
  2. Autonomous conversational agents for loneliness, social isolation, depression, and anxiety in older people without cognitive impairment: Systematic review and meta-analysis.
    Satake Y, Costello H, Naran N, Ishimaru D, Ikeda M, Howard R.
    Psychological Medicine. 2026;56:e27.
  3. Association between cerebrospinal fluid volume and frailty in community-dwelling older adults: a cross-sectional study.
    Yoshiura K, Hidaka Y, Suehiro T, Kajitani N, Koyama A, Miyagawa Y, Tsunoda N, Ishikawa T, Fukuhara R, Hashimoto M, Ikeda M, Shimodozono M, Ishii K, Takebayashi M.
    Fluids and Barriers of the CNS. 2026;23:36.
  4. Case report: A five-case series of 18-month home use of a conversational companion robot for psychological support in older people with mild cognitive impairment or late-onset psychosis.
    Nagata Y, Satake Y, Yamazaki R, Nishio S, Ishiguro H, Ikeda M.
    Frontiers in Psychiatry. 2026;16:1700340.
  5. Comparison of EEG features between patients with and without reduced 123I-MIBG myocardial scintigraphy uptake: A 6-year retrospective study of 230 patients with suspected dementia.
    Omori H, Hata M, Shigenobu K, Takahashi S, Miyazaki Y, Eto M, Nakagawa Y, Hirashima A, Muto K, Shinosaki K, Ikeda M.
    International Psychogeriatrics. 2026:100197.
  6. Associations of living alone and loneliness with neuropsychiatric symptoms in individuals with mild cognitive impairment: A retrospective cross-sectional study.
    Takeda K, Kanemoto H, Suehiro T, Satake Y, Taomoto D, Katakami S, Yoshiyama K, Ikeda M.
    Psychiatry and Clinical Neurosciences Reports. 2026;5(1):e70299.
  7. Characteristics of Older Adults With Domestic Squalor in Japan: A Cross-Sectional Study.
    Taomoto D, Kanemoto H, Suehiro T, Satake Y, Nakamuta N, Hotta M, Suzuki M, Yoshiyama K, Miyoshi T, Kashiwagi K, Shigenobu K, Hashimoto M, Ikeda M.
    Psychogeriatrics. 2026;26(2):e70150.